Pathogenesis of Candida albicans infection following antibiotic therapy. III. The effect of antibiotics on the incidence of Candida albicans in the intestinal tract of mice
Huppert, M.; Cazin, J.; Smith, H.
Journal of Bacteriology 70(4): 440-447
1955
ISSN/ISBN: 0021-9193
PMID: 13263314
Accession: 013786421
In further studies on the treatment of Candida albicans infection at the University of North Carolina School of Medicine all the antibiotics used (chlorotetracycline hydrochloride alone and with parabens, chloromycetin, oxytetracycline hydrochloride, dihydrostrep-tomycin, magnamycin, neomycin, oxytetracycline (amphoteric), erythromycin, penicillin, and tetracycline), when administered orally, promoted the establishment of C. albicans in the intestinal flora of mice.
PDF emailed within 1 workday: $29.90
Related References
Huppert, M.; Cazin, J. 1955: Pathogenesis of Candida albicans infection following antibiotic therapy. II. Further studies of the effect of antibiotics on the in vitro growth of Candida albicans Journal of Bacteriology 70(4): 435-439Huppert, M.; Macpherson, D.A.; Cazin, J. 1953: Pathogenesis of Candida albicans infection following antibiotic therapy. I. The effect of antibiotics on the growth of Candida albicans Journal of Bacteriology 65(2): 171-176
Henry Stanley, M.J.; Garni, R.M.; Johnson, M.A.; Bendel, C.M.; Wells, C.L. 2005: Comparative abilities of Candida glabrata and Candida albicans to colonize and translocate from the intestinal tract of antibiotic-treated mice Microbial Ecology in Health and Disease 17(3): 129-137
Schneider, H.; Vogt, A.; Müller, R.; Müller, J.; Kuttin, E.S. 2009: Anti-Candida albicans Antibody Levels and in vitro Lymphoproliferative Response to Candida albicans in Neonates and their Mothers/Anti-Candida-albicans-Spiegel und Candida-albicans-bedingte Lymphozyten-Stimulation in vitro bei Neugeborenen und ihren Mütte Mycoses 29(1): 10-20
Basu, S.; Quilici, C.; Zhang, H-Hua.; Grail, D.; Dunn, A.R. 2008: Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans Growth Factors 26(1): 23-34
Brunet, J.L.; Cozon, G.; Saintelaudy, J.; Boissel, J.P.; Delair, S.; Peyramond, D. 1997: Apport au diagnostic de l'hypersensibilité de type retardé anormale à candida albicans : Essai de caractérisation par activation de cellules sensibilisées avec des dilutions successives de Candida albicans - Contribution to the diagnosis of abnormal delayed type hypersensitivity to candida albicans : Characterisation testing by activation of sensitised cells with successive dilutions of Candida albicans Allergie et Immunologie (Paris) 29(8): 233-238
Balogh, E.; Kakuk, G.; Halmy, K.; Szabolcsi, M. 1971: Experimental investigation of immunreactivity against Candida albicans. 1. Reaction of rabbits immunized with Candida albicans and challenged with living Candida albicans Mykosen 14(8): 385-392
Kanbe, T.; Kurimoto, K.; Hattori, H.; Iwata, T.; Kikuchi, A. 2005: Rapid identification of Candida albicans and its related species Candida stellatoidea and Candida dubliniensis by a single PCR amplification using primers specific for the repetitive sequence (RPS) of Candida albicans Journal of Dermatological Science 40(1): 43-50
Wang, H.; Wu, D.-W.; Han, H.; Yue, J.-F.; Zhang, F.; Shan, T.-C.; Guo, H.-P.; Yin, M. 2014: Antibiotics exposure, risk factors, and outcomes with Candida albicans and non-Candida albicans candidemia. Results from a multi-center study Saudi Medical Journal 35(2): 153-158
Udayalaxmi; Jacob, S.; D'Souza, D. 2014: Comparison Between Virulence Factors of Candida albicans and Non-Albicans Species of Candida Isolated from Genitourinary Tract Journal of Clinical and Diagnostic Research: Jcdr 8(11): Dc15-Dc17
Meenan, F.O. 1957: The incidence of Candida albicans after antibiotic therapy Irish Journal of Medical Science 378: 265-266
Geniaux, M. 1996: Infections cutanéo-muqueuses à Candida albicans : épidémiologie, diagnostic, traitement - Cutaneomucosal infection with Candida albicans la Revue du Praticien (Paris) 46(3): 350-354
Shigemura, K.; Osawa, K.; Jikimoto, T.; Yoshida, H.; Hayama, B.; Ohji, G.; Iwata, K.; Fujisawa, M.; Arakawa, S. 2014: Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection Journal of Antibiotics 67(4): 311-314
Crist, A.E.Jr; Dietz, T.J.; Kampschroer, K.; Rudy, F.R. 1995: Comparison of the MUREX C albicans, Albicans-Sure, and Bacti Card Candida with the germ tube test for the presumptive identification of Candida albicans Abstracts of the General Meeting of the American Society for Microbiology 95: 72
Böhme, H.; Ziegler, H. 1978: The colonization of the intestinal tract by Candida albicans and the occurrence of anti-Candida-antibodies in humans Dermatologische Monatschrift 164(9): 652-655
Weickert, C.; Richard, G. 1987: Defekte der Killer-T-Lymphozyten als Ursache einer endogenen Candida albicans-Endophthalmitis - Déficit de la fonction des lymphocytes T conduisant à une endophtalmie à Candida albicans - A defect in the function of killer-T-lymphocytes leads to a Candida albicans endophtalmitis Deutschen Ophthalmologischen Gesellschaft. Tagung 84 84(4): 350-352
Damms, T.; Bohnke, M. 1989: Spezifität der humoralen Immunantwort gegen Candida albicans bei Patienten mit Panuveitis - Spécificité de la réponse immunitaire à Candida albicans chez les patients atteints de panuvéite - Specificity of the humoral response to Candida albicans in patients with panuveitis Tagung der Deutschen Ophthalmologischen Gesellschaften 86 86(4): 323-326
Ishii, N.; Yamamoto, M.; Lahm, H.W.; Lizumi, S.; Yoshihara, F.; Nakayama, H.; Arisawa, M.; Aoki, Y. 1997: A DNA-binding protein from Candida albicans that binds to the RPG box of Saccharomyces cerevisiae and the telomeric repeat sequence of C. albicans : Candida albicans Microbiology (Reading) 143: 417-427
Spiering, M.J.; Moran, G.P.; Chauvel, M.; Maccallum, D.M.; Higgins, J.; Hokamp, K.; Yeomans, T.; d'Enfert, C.; Coleman, D.C.; Sullivan, D.J. 2010: Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model Eukaryotic Cell 9(2): 251-265
Ou, H-Tz.; Lee, T-Ying.; Chen, Y-Chun.; Charbonneau, C. 2017: Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species Bmc Infectious Diseases 17(1): 481